LPL Financial
IOVA icon

LPL Financial’s Iovance Biotherapeutics IOVA Stock Holding History

LPL Financial’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,900
Closed -$69.8K – 6279
2026
Q1 		$69.8K Buy
+19,900
New +$63.6K ﹤0.01% 5735
2025
Q3 		– Sell
-70,000
Closed -$120K – 5895
2025
Q2 		$120K Buy
70,000
+50,000
+250% +$124K ﹤0.01% 5228
2025
Q1 		$66.6K Buy
+20,000
New +$103K ﹤0.01% 5114
2024
Q4 		– Sell
-10,000
Closed -$93.9K – 5371
2024
Q3 		$93.9K Buy
+10,000
New +$94.7K ﹤0.01% 4903

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

LPL Financial's IOVA Position: Q2 2026 in Review

LPL Financial increased its Iovance Biotherapeutics (IOVA) stake by 16% in Q2 2026, buying an estimated $349K and bringing the position to 661,075 shares worth $2.75M. The position accounts for ﹤0.01% of the portfolio, ranked #3394.

LPL Financial first reported a position in IOVA in Q3 2019 and has held it in 24 quarters since. The position peaked at $3.57M in Q1 2024. 293 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • LPL Financial held 661,075 shares of Iovance Biotherapeutics worth $2.75M as of Q2 2026.
  • LPL Financial bought 91,841 Iovance Biotherapeutics shares in Q2 2026, an estimated $349K.
  • Iovance Biotherapeutics made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #3394 holding.
  • LPL Financial first reported a position in Iovance Biotherapeutics in Q3 2019 and has held it in 24 quarters since.
  • LPL Financial's Iovance Biotherapeutics position peaked at $3.57M in Q1 2024.
  • 293 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.